每经记者:潘婷近日,21世纪金融研究院发表了一篇署名文章——《预期升温背后:平安好医生打造中国HMO新样板》。这篇文章的背景,是摩根士丹利在2025年末发布的一篇行业研报。研报中不仅将中国平安目标价从70元上调至近90元,更预测旗下平安好医生股价有望年内翻倍。文章中指出,“基于庞大的潜在市场,并凭借清晰的商业模式与盈利模式,领先多年的先发优势与清晰护城河,平安好医生正试图参照美国联合健康的成功路径...
Source Link每经记者:潘婷近日,21世纪金融研究院发表了一篇署名文章——《预期升温背后:平安好医生打造中国HMO新样板》。这篇文章的背景,是摩根士丹利在2025年末发布的一篇行业研报。研报中不仅将中国平安目标价从70元上调至近90元,更预测旗下平安好医生股价有望年内翻倍。文章中指出,“基于庞大的潜在市场,并凭借清晰的商业模式与盈利模式,领先多年的先发优势与清晰护城河,平安好医生正试图参照美国联合健康的成功路径...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.